Elsevier, a global leader in information analytics specializing in science and health, has launched a new resource to aid healthcare workers on the front lines of managing the novel coronavirus health crisis. The covid-19 Healthcare Hub provides free access to toolkits, expert insights, research resources and covid-19 guidelines. The Hub’s toolkits include evidence-based clinical overviews, drug monographs, care plans, order sets, and procedure videos for clinicians delivering care and information to patients.
Clinicians will also find the latest information and guidelines from government health agencies, medical societies and public health organizations for diagnosis, testing and treatment of covid-19 patients. “As clinicians manage high patient volumes, health systems and providers urgently need access to the latest evidence-based information,” said John Danaher, MD, president, Global Clinical Solutions, Elsevier. “The Healthcare Hub is a tool to support the medical community during this crisis.”
That same performance boost is also applied to the onboard Qualcomm AI Engine. What this essentially means is that the chipset is more efficient in managing power while gaming, which in turn enables it to conserve battery power and be more efficient. Beyond these points, everything else on the 768G 5G looks more or less the same as its predecessor. It still gets the same Snapdragon X52 modem that supports 5G connectivity on both the mmWave and sub-6GHz wavelength. As well as standalone and non-standalone 5G networks.
The covid-19 Healthcare Hub’s mobile-friendly, responsive format allows clinicians to access the patient care information they need from their mobile phones, tablets or computers. “We designed the Healthcare Hub to provide a seamless user experience that ensures vital content is accessible – wherever and whenever it is needed,” said Dr. Danaher.
Healthcare professionals can access Elsevier’s covid-19 Healthcare Hub by visiting elsevier.health. The covid-19 Healthcare Hub is part of Elsevier’s contributions to help researchers and clinicians during this global crisis. Elsevier’s Novel Coronavirus Information Center provides the latest early stage and peer-reviewed research on the novel coronavirus and covid-19.